C4 Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$2.38(as of Oct 17, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

C4 Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.38
Ticker SymbolCCCC
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees110
CountyUSA
Market Cap$220.2M
EBIDTA-121.6M
10-Day Moving Average2.26
P/E Ratio-1.51
20-Day Moving Average2.29
Forward P/E Ratio0.00
50-Day Moving Average2.54
Earnings per Share-1.59
200-Day Moving Average2.28
Profit Margin-402.60%
RSI49.37
Shares Outstanding92.9M
ATR0.25
52-Week High6.52
Volume2,487,600
52-Week Low1.09
Most Recent Support Level1.99
Book Value174.1M
Most Recent Resistance Level2.82
P/B Ratio0.97
Upper Keltner2.84
P/S Ratio4.91
Lower Keltner1.73
Debt-to-Equity Ratio2.84
Next Earnings Date10/30/2025
Cash Surplus33.7M
Next Ex-Dividend DateUnknown

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 clinical trials targeting IKZF1 and IKZF3 for multiple myeloma and non-Hodgkin lymphomas, including peripheral T-cell lymphoma and mantle cell lymphoma. The company is also developing CFT1946, an orally bioavailable BiDAC degrader targeting BRAF V600 mutant that is in Phase 1/2 clinical trials to treat melanoma, colorectal cancer, and other solid malignancies; and CFT8919, an orally bioavailable, allosteric, and mutant-selective BiDAC degrader of epidermal growth factor receptor with an L858R mutation in non-small cell lung cancer. It has strategic collaborations with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; Biogen MA, Inc.; Betta Pharmaceuticals, Co., Ltd.; Merck KGaA; and Merck Sharp & Dohme, LLC, as well as Calico Life Sciences LLC. The company was incorporated in 2015 and is headquartered in Watertown, Massachusetts.

C4 Therapeutics Inc In Our Stock Scanner

As of Oct 17, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.